产品封面图

Recombinant Human IL-17/IL-17A

收藏
  • ¥1200
  • novoprotein
  • CN
  • C021
  • 2025年12月24日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 英文名

      Recombinant Human IL-17/IL-17A

    • 库存

      10

    • 供应商

      研卉生物

    • 规格

      50ug

    Recombinant Human IL-17/IL-17A

    Recombinant Human IL-17/IL-17A (C021)

    产品说明(Description)

    Recombinant Human Interleukin-17A is produced by our E.coli expression system and the target gene encoding Gly24-Ala155 is expressed.

    Accession #: Q16552

    Known as: Interleukin-17A; IL-17; IL-17A; Cytotoxic T-Lymphocyte-Associated Antigen 8; CTLA-8; IL17A; CTLA8; IL17

    制剂(Formulation)

    Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

    质量控制(Quality Control)

    Purity: Greater than 95% as determined by reducing SDS-PAGE.

    Endotoxin: Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.

    Bioactivity: Measured by its ability to induce IL-6 secretion by NIH-3T3 mouse embryonic fibroblast cells.

    The ED50 for this effect is 1-7 ng/ml.

    图片1.png

    复溶(Reconstitution)

    Always centrifuge tubes before opening. Do not mix by vortex or pipetting.
    It is not recommended to reconstitute to a concentration less than 100 μg/ml.
    Dissolve the lyophilized protein in distilled water.
    Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

    背景(Background)

    Interleukin-17 is a potent pro-inflammatory cytokine produced by activated memory T cells. There are at least six members of the IL-17 family in humans and in mice. As IL-17 shares properties with IL-1 and TNF-alpha, it may induce joint inflammation and bone and cartilage destruction. This cytokine is found in synovial fluids of patients with rheumatoid arthritis, and produced by rheumatoid arthritis synovium. It increases IL-6 production, induces collagen degradation and decreases collagen synthesis by synovium and cartilage and proteoglycan synthesis in cartilage. IL-17 is also able to increase bone destruction and reduce its formation. Blocking of interleukin-17 with specific inhibitors provides a protective inhibition of cartilage and bone degradation.

    1993年首次发现IL-17A以来,现已有6IL-17家族细胞因子被发现,分别为IL-17AIL-17BIL-17CIL-17DIL-17EIL-17FIL-17T细胞诱导的炎症反应的早期启动因子,可以通过促进释放前炎性细胞因子来放大炎症反应。IL-17与受体结合后,迅速招募Act1并泛素化TNF-受体相关因子6 (TRAF6),进而通过MAP 激酶途径和核转录因子kB (Nuclearfactor kB, NF-kB)途径发挥其生物学作用。Th17细胞能够分泌产生IL-17AIL-17FIL-6以及TNFα等,这些细胞因子可以集体动员、募集及活化中性粒细胞。Th17细胞产生的IL-17能有效地介导中性粒细胞动员的兴奋过程,从而有效地介导了组织的炎症反应。曾发表在《Nature》中的一项研究报告指出,IL-17失调与急性炎症反应密切相关,可引起银屑病、类风湿性关节炎和多发性硬化症等疾病产生。IL-17家族成员都与炎症的发生相关,其中IL-17F来源和功能与IL-17A最为相似,同样具有和IL-17A相同的抗感染作用,并且表现出相对较低的促炎活性。IL-17AIL-17F同源二聚体的形式存在,但也可以作为一种异源二聚体产生,三种形式均与IL-17 RAIL-17 RC异二聚体结合诱导信号。其中,IL-17A同源二聚体诱导信号最强,其次是IL-17A/F,最后是IL-17F同源二聚体。重组人源化抗IL-17A单克隆抗体就是通过与IL-17A高亲和力结合并选择性地阻断IL-17A与其受体IL-17RA/IL-17RC的结合,从而阻断下游信号通路的激活和炎性因子的释放,能有效地缓解自身免疫性疾病的症状。

    FOR RESEARCH USE ONLY仅限科学研究

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 9.18 Nature 子刊:IL- 17 激活 NOTCH 信号通路,参与细胞增殖

      感受低温的功能,并在小鼠的背根神经节(DRG)得到实验证明。该工作发现谷氨酸受体蛋白 GLR- 3 /Gluk2 能够感受低于 18 摄氏度的低温,是目前科学界发现的首个低温冷受体,并且其感受低温的功能不受其离子通道功能的影响,是偶联下游 G 蛋白来行使其冷信号传递功能。原文检索:A Cold-Sensing Receptor Encoded by a Glutamate Receptor Gene ② Nature 子刊:IL- 17 激活 NOTCH 信号通路,参与细胞增殖近年来的研究发现,Th17

    • Construction of Recombinant Human Cytomegalovirus

      The use of reverse genetics to generate recombinant viruses allows the researcher to investigate the exact functional significance of particular viral genes during the virus life cycle, by means of their deletion or modification in the viral

    • Delivery of Recombinant Adenoviruses to Human Saphenous Vein

      The human saphenous vein is the most commonly used conduit for coronary artery bypass grafting owing to its ready availability, ease of harvesting, and favorable surgical handling (1 ). However, it suffers from a progressive decline

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2025
    上海研卉生物科技有限公司
    2025年07月08日询价
    ¥580
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2026年01月23日询价
    ¥3990
    北京百普赛斯生物科技股份有限公司
    2025年11月13日询价
    ¥13800
    北京百奥创新科技有限公司
    2025年06月16日询价
    ¥4000
    青木生物技术(武汉)有限公司
    2025年12月27日询价
    Recombinant Human IL-17/IL-17A
    ¥1200